PUBLIC CONTRACT · 2024
1231924 Medicamentos Exclusivos Ciclossilicato de Zicórnio Sódico 5g Pó susp Oral Saq Ano 2024
- Contract value
- €46,423.18
- Signed on
- 26 March 2024
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 11311918PUBLISHED SUBJECT
1231924 Medicamentos Exclusivos Ciclossilicato de Zicórnio Sódico 5g Pó susp Oral Saq Ano 2024
Parties involved
- Place of performance
- Portugal, Porto, Vila Nova de Gaia
- NUTS region
- PT11A - Área Metropolitana do Porto
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- ASTRAZENECA - PROD.FARMACEUTICOS, LDA. · Tax ID 502942240
Values and timeline
- Contract price
- €46,423.18
- Procedure base price
- €46,645.67
- Total effective price
- Not reported on Portal BASE
- Publication date
- 27 March 2025
- Award date
- 12 March 2024
- Signing date
- 26 March 2024
- Performance period
- 340 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 24.º, n.º 1, alínea e), subalínea iii) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL 111-B/2017) e Lei n.º 30/2021, de 21.05 e DLR no 34/2008/M, de 14.08 (DLR n.º 6/2018/M)
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 7537462
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.